Pharmacokinetics and intramuscular bioavailability of amikacin in chickens following single and multiple dosing

The pharmacokinetics of amikacin were studied in healthy mature female chickens (n = 6). Single doses of amikacin were injected as an i.v. bolus (10 mg/kg) and i.m. (20 mg/kg) into the same birds with a 30-day rest period between treatments. Amikacin was determined by the fluorescence polarization immunoassay method. The i.v. pharmacokinetics could be described by a two-compartment model with a t1/2 alpha of 0.150 +/- 0.064 h and a t1/2 beta of 1.44 +/- 0.34 h. The total body clearance was 0.109 +/- 0.017 1/h/kg and the volume of distribution at steady-state was 0.193 +/- 0.060 l/kg. Following a single i.m. injection, the peak plasma concentration (Cmax) was 50.79 +/- 4.05 micrograms/ml and occurred at 0.50 +/- 0.26 h. The i.m. extent of absorption was 91.2 +/- 17.6%. Simultaneous modeling of i.v. and i.m. results provided estimates of an absorption half-life of 0.480 +/- 0.158 h. The i.m. pharmacokinetics after repeated administration were studied following the tenth dose (20 mg/kg, every 8 h). The Cssmax was 38.58 +/- 6.96 micrograms/ml and occurred at 0.79 +/- 0.37 h, and the biological half-life of amikacin was 1.86 +/- 0.47 h. The multiple dosing yielded peak concentrations of 39 micrograms/ml and trough concentrations of 3.26 micrograms/ml. Based on these data, the recommended amikacin dosage in chickens is 20 mg/kg body weight every 8 h.     

The effect of various antibacterial preparations on the in vitro morphology and chemotactic response of equine neutrophils

Two independent assay systems were used to study the effect of three antibacterial preparations on in vitro morphology and chemotaxis of equine neutrophils. Incubation of neutrophils with high (200 micrograms/ml) and medium (20 micrograms/ml) concentrations of neomycin impaired their response to standard chemoattractants. Trimethoprim/sulfadoxine (0.4/2.0 micrograms/ml-40/200 micrograms/ml) and benzylpenicillin (0.25-25 micrograms/ml) had no effect. Neutrophils collected from geldings 2 and 24 h after neomycin (5 mg/kg) administration had impaired responses to standard chemoattractants. Benzylpenicillin (13.2 mg/kg) had no effect.     

Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug

Norfloxacin was given to 6 healthy dogs at a dosage of 5 mg/kg of body weight IV and orally in a complete crossover study, and orally at dosages of 5, 10, and 20 mg/kg to 6 healthy dogs in a 3-way crossover study. For 24 hours, serum concentration was monitored serially after each administration. Another 6 dogs were given 5 mg of norfloxacin/kg orally every 12 hours for 14 days, and serum concentration was determined serially for 12 hours after the first and last administration of the drug. Complete blood count and serum biochemical analysis were performed before and after 14 days of oral norfloxacin administration, and clinical signs of drug toxicosis were monitored twice daily during norfloxacin administration. Urine concentration of norfloxacin was determined periodically during serum acquisition periods. Norfloxacin concentration was determined, using high-performance liquid chromatography with a limit of detection of 25 ng of norfloxacin/ml of serum or urine. Serum norfloxacin pharmacokinetic values after single IV dosing in dogs were best modeled, using a 2-compartment open model, with distribution and elimination half-lives of 0.467 and 3.56 hours (harmonic means), respectively. Area-derived volume of distribution (Vd area) was 1.77 +/- 0.69 L/kg (arithmetic mean +/- SD), and serum clearance (Cls) was 0.332 +/- 0.115 L/h/kg. Mean residence time was 4.32 +/- 0.98 hour. Comparison of the area under the curve (AUC; derived, using model-independent calculations) after iv administration (5 mg/kg) with AUC after oral administration (5 mg/kg) in the same dogs indicated bioavailability of 35.0 +/- 46.1%, with a mean residence time after oral administration of 5.71 +/-2.24 hours. Urine concentration was 33.8 +/- 15.3 micrograms/ml at 4 hours after a single dose of 5 mg/kg given orally, whereas concentration after 20 mg/kg was given orally was 56.8 +/- 18.0 micrograms/ml at 6 hours after dosing. Twelve hours after drug administration, urine concentration was 47.4 +/- 20.6 micrograms/ml after the 5-mg/kg dose and 80.6 +/- 37.7 micrograms/ml after the 20/mg/kg dose.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of probenecid administration on cephapirin pharmacokinetics and concentrations in mares

Cephapirin (20 mg/kg of body weight, IV) was administered before and after 3 doses of probenecid (25, 50, or 75 mg/kg, intragastrically, at 12-hour intervals) to 2 mares. Clearance and apparent volume of distribution, based on area under the curve, were negatively correlated with probenecid dose. Clearance of cephapirin was decreased by approximately 50% by administration of 50 mg of probenecid/kg. Serum, synovial fluid, peritoneal fluid, CSF, urinary, and endometrial concentrations of cephapirin were determined after 5 doses of cephapirin (20 mg/kg, IM, at 12-hour intervals) without and with concurrently administered probenecid (50 mg/kg, intragastrically) to 6 mares, including the 2 mares given cephapirin, IV. Highest mean serum cephapirin concentrations were 16.1 +/- 2.16 micrograms/ml at 0.5 hour after the 5th cephapirin dose [postinjection (initial) hour (PIH) 48.5] in mares not given probenecid and 23.7 +/- 1.30 micrograms/ml at 1.5 hours after the 5th cephapirin dose (PIH 49.5) in mares given probenecid. Mean peak peritoneal fluid and synovial fluid cephapirin concentrations were 6.2 +/- 0.57 micrograms/ml and 6.6 +/- 0.58 micrograms/ml, respectively, without probenecid administration and 12.3 +/- 0.46 micrograms/ml and 10 +/- 0.78 micrograms/ml, respectively, with concurrent probenecid administration. Mean trough cephapirin concentrations for peritoneal and synovial fluids in mares given probenecid were 2 to 3 times higher than trough concentrations in mares not given probenecid. Overall mean cephapirin concentrations were significantly higher for serum, peritoneal fluid, synovial fluid, and endometrium when probenecid was administered concurrently with cephapirin (P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)     

益生菌和两种多糖合用对海兰褐蛋鸡免疫功能影响的研究

 试验选用２００只１日龄海蓝褐蛋雏鸡,分为６个组,每组３０只,对照组饲喂基础日粮,试验组在基础日粮的基础上分别添加１０７ ｃｆｕ／ｇ益生素,３００ ｍｇ／ｋｇ黄芪多糖,３０ ｍｇ／ｋｇ酵母多糖,５×１０６ ｃｆｕ／ｇ益生素＋１５０ ｍｇ黄芪多糖和５×１０６ ｃｆｕ／ｇ益生素＋１５ ｍｇ酵母多糖,试验周期５０ d。试验结果表明：益生素和多糖均能提高雏鸡的生长性能,免疫器官指数和抗体滴度和血清溶菌酶含量,而以益生素＋黄芪多糖组效果最好,而益生素＋酵母多糖组在本次试验中则没有体现出复配优势。     

Serum concentrations of cefepime (BMY-28142), a broad-spectrum cephalosporin, in dogs.

Serum concentrations of cefepime (BMY-28142) were determined for four dosing regimes, 10 mg/kg or 20 mg/kg, given as single subcutaneous (SC) or intramuscular injections (IM) to dogs. Serial serum samples were analyzed for the presence of cefepime by high-performance liquid chromatography. In experiment 1, the overall mean (+/- SEM) serum concentration (for a 12-hour period) after a dose of 20 mg/kg for SC and IM routes (4.9 +/- 0.74 micrograms/ml and 5.5 +/- 0.63 micrograms/ml, respectively) was twice that for the 10 mg/kg dose given either SC or IM (2.2 +/- 0.31 micrograms/ml and 2.8 +/- 0.47 micrograms/ml, respectively). There was no significant difference (p greater than 0.05) in mean serum concentrations for SC and IM routes of administration at the same dosage. In subsequent experiments, 5 doses of cefepime (20 mg/kg) were administered IM at 12-hour (experiment 2) or 24-hour (experiment 3) intervals. The mean (+/- SEM) peak serum concentration was 12.1 +/- 1.59 micrograms/ml, 2 hours after the 2nd injection in experiment 2. In experiment 3, the mean (+/- SEM) peak serum concentration was 10.9 +/- 1.34 micrograms/ml, 4 hours after the 1st injection. Mean trough concentrations in experiment 2 were greater than or equal to 0.5 microgram/ml and less than or equal to 0.5 in experiment 3. Multiple IM doses produced transient edema at the injection site and mild lameness in all dogs. Cefepime was highly active against single canine isolates of Staphylococcus intermedius, Pseudomonas aeruginosa and Escherichia coli, with minimum inhibitory concentrations of 0.125 microgram/ml, 1 microgram/ml and 0.3 microgram/ml, respectively.     

Combined pharmacokinetics of gentamicin in pony mares after a single intravenous and intramuscular administration

Healthy mature pony mares (n = 6) were given a single dose of gentamicin (5 mg/kg of body weight) IV or IM 8 days apart. Venous blood samples were collected at 0, 5, 10, 20, 30, and 45 minutes and at 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 12, 18, 24, 30, 36, 40, and 48 hours after IV injection of gentamicin, and at 10, 20, 30, and 45 minutes and at 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 12, 18, 24, and 30 hours after IM injection of gentamicin. Gentamicin serum concentration was determined by a liquid-phase radioimmunoassay. The combined data of IV and IM treatments were analyzed by a nonlinear least-square regression analysis program. The kinetic data were best fitted by a 2-compartment open model, as indicated by residual trends and improvements in the correlation of determination. The distribution phase half-life was 0.12 +/- 0.02 hour and postdistribution phase half-life was 1.82 +/- 0.22 hour. The volume of the central compartment was 115.8 +/- 6.0 ml/kg, volume of distribution at steady state was 188 +/- 9.9 ml/kg, and the total body clearance was 1.27 +/- 0.18 ml/min/kg. Intramuscular absorption was rapid with a half-life for absorption of 0.64 +/- 0.14 hour. The extent of absorption was 0.87 +/- 0.14. Kinetic calculations predicted that IM injections of 5 mg of gentamicin/kg every 8 hours would provide average steady-state serum concentrations of 7.0 micrograms/ml, with maximum and minimum steady-state concentrations of 16.8 and 1.1 micrograms/ml, respectively.     

贵州南五味子多糖对鸡细胞免疫和体液免疫的影响

选用600只15日龄海兰褐雏鸡,随机分为5个处理,每个处理3个重复,每个重复40只鸡,皮下注射贵州南五味子多糖10、20mg/kg、黄芪多糖20mg/kg、环磷酰胺40mg/kg及生理盐水。空白对照组,连续给药3d后免疫新城疫疫苗,分别于免疫后7、14、21、28和35d时,各处理组随机抽取8只鸡检测各项免疫指标,探讨不同处理组对雏鸡免疫功能的影响。本试验结果表明,皮下注射10～20mg/kg贵州南五味子多糖可显著促进鸡外周血T淋巴细胞增殖,IL-2的产生(P<0.01);可使CD4+/CD8+淋巴细胞比值明显升高(P<0.01);可使鸡体内抗ND抗体滴度明显升高(P<0.01);可使法氏囊、胸腺的脏器指数均明显升高(P<0.01)。     

Pharmacokinetics of single-dose intravenous or intramuscular administration of gentamicin in roosters

Healthy mature roosters (n = 10) were given gentamicin (5 mg/kg of body weight, IV) and, 30 days later, another dose IM. Serum concentrations of gentamicin were determined over 60 hours after each drug dosing, using a radioimmunoassay. Using nonlinear least-square regression methods, the combined data of IV and IM treatments were best fitted by a 2-compartment open model. The mean distribution phase half-life was 0.203 +/- 0.075 hours (mean +/- SD) and the terminal half-life was 3.38 +/- 0.62 hours. The volume of the central compartment was 0.0993 +/- 0.0097 L/kg, volume of distribution at steady state was 0.209 +/- 0.013 L/kg, and the total body clearance was 46.5 +/- 7.9 ml/h/kg. Intramuscular absorption was rapid, with a half-life for absorption of 0.281 +/- 0.081 hours. The extent of IM absorption was 95 +/- 18%. Maximal serum concentration of 20.68 +/- 2.10 micrograms/ml was detected at 0.62 +/- 0.18 hours after the dose. Kinetic calculations predicted that IM injection of gentamicin at a dosage of 4 mg/kg, q 12 h, and 1.5 mg/kg, q 8 h, would provide average steady-state serum concentrations of 6.82 and 3.83 micrograms/ml, with minimal steady-state serum concentrations of 1.54 and 1.50 micrograms/ml and maximal steady-state serum concentrations of 18.34 and 7.70 micrograms/ml, respectively.     

Florfenicol in non-lactating dairy cows: pharmacokinetics, binding to plasma proteins, and effects on phagocytosis by blood neutrophils

Serial blood samples were collected and plasma concentrations of florfenicol (FLO) were measured following the administration of an intravenous bolus of 50 mg/kg FLO to five healthy non-lactating dairy cows. A triexponential equation provided the best fit of the data for four of the five cows. The mean value for beta corresponded to a half-life of 3.2 h. The mean apparent volume of distribution was 0.67 l/kg, and the mean body clearance was 0.15 l/kg/h. The extent of binding of FLO to bovine plasma proteins was determined in vitro at concentrations of 5 micrograms/ml and 50 micrograms/ml by equilibrium dialysis and ultrafiltration. The drug was 18% and 19% bound by equilibrium dialysis, and 23% and 19% bound by ultrafiltration, at 5 micrograms/ml and 50 micrograms/ml, respectively. Phagocytosis of 32phosphorus-labelled Staphylococcus aureus by bovine blood neutrophils was compared in vitro between neutrophils incubated in phosphate-buffered saline alone or in combination with 5, 125, or 1000 micrograms/ml chloramphenicol or FLO. There was no significant effect of chloramphenicol at any concentration. Florfenicol significantly inhibited phagocytosis at all concentrations, but the percentage inhibition was small. The clinical significance, if any, of this effect of FLO remains to be demonstrated.     

Serum and skin concentrations after multiple-dose oral administration of trimethoprim-sulfadiazine in dogs.

Six healthy adult mixed breed dogs were each given 5 oral doses of trimethoprim (TMP)/sulfadiazine (SDZ) at 2 dosage regimens: 5 mg of TMP/kg of body weight and 25 mg of SDZ/kg every 24 hours (experiment 1) and every 12 hours (experiment 2). Serum and skin concentrations of each drug were measured serially throughout each experiment and mean serum concentrations of TMP and SDZ were determined for each drug for 24 hours (experiment 1) and 12 hours (experiment 2) after the last dose was given. In experiment 1, mean serum TMP concentration was 0.67 +/- 0.02 micrograms/ml, and mean skin TMP concentration was 1.54 +/- 0.40 micrograms/g. Mean serum SDZ concentration was 51.1 +/- 12.2 micrograms/ml and mean skin SDZ concentration was 59.3 +/- 9.8 micrograms/g. In experiment 2, mean serum TMP concentration was 1.24 +/- 0.35 micrograms/ml and mean skin TMP concentration was 3.03 +/- 0.54 micrograms/g. Mean serum SDZ concentration was 51.6 +/- 9.3 micrograms/ml and mean skin SDZ concentration was 71.1 +/- 8.2 micrograms/g. After the 5th oral dose in both experiments, mean concentration of TMP and SDZ in serum and skin exceeded reported minimal inhibitory concentrations of TMP/SDZ (less than or equal to 0.25/4.75 micrograms/ml) for coagulase-positive Staphylococcus sp. It was concluded that therapeutically effective concentrations in serum and skin were achieved and maintained when using the manufacturer's recommended dosage of 30 mg of TMP/SDZ/kg (5 mg of TMP/kg and 25 mg of SDZ/kg) every 24 hours.     

不同剂量环磷酰胺对小鼠免疫功能抑制作用的研究

旨在观察不同剂量及不同给药方式下环磷酰胺对健康小鼠的免疫抑制作用,探索建立小鼠环磷酰胺免疫抑制模型的方法。采用腹腔注射法给予小鼠不同剂量的环磷酰胺,通过测定免疫器官指数,血清谷丙转氨酶、谷草转氨酶、尿素氮、肌酐含量,血液白细胞数量,脾淋巴细胞转化率等指标,评价环磷酰胺对小鼠机体免疫力以及肝肾功能的影响。结果表明,连续7 d分别给予小鼠腹腔注射10、20、30、40 mg/（kg·BW）的环磷酰胺和单次注射150 mg/（kg·BW）的环磷酰胺,均可对小鼠产生不同程度的免疫抑制作用,并引起肝肾功能相关指标的变化;低剂量多次注射环磷酰胺产生的免疫抑制效果优于高剂量单次注射,且在低剂量多次注射时,免疫抑制效果随注射剂量的升高而增强。连续7d给予健康小鼠腹腔注射30~40 mg/（kg·BW）的环磷酰胺,可建立小鼠免疫抑制模型。     

黄芩抗鸡大肠杆菌作用的研究

通过体外和体内两种方法研究黄芩抗鸡大肠杆菌作用.通过体外抑菌作用测定黄芩水煎液对鸡大肠杆菌的最小抑菌浓度（MIC）为2.5g/ml;体内抑菌作用通过对7日龄雏鸡的攻毒与治疗试验来研究,体内治疗药物浓度5g/ml可使90%以上雏鸡获得保护,10g/ml可使100%雏鸡获得保护.以上说明黄芩可以对抗鸡大肠杆菌,可以防治鸡的大肠杆菌病.     

Spinal fluid concentrations of mepivacaine in horses and procaine in cows after thoracolumbar subarachnoid analgesia

The CSF concentrations of mepivacaine in 10 Standardbred horses and of procaine in 10 Holstein cows given the drugs by thoracolumbar subarachnoid injection were determined. Mepivacaine hydrochloride was injected into the horses (502 +/- 60.5 kg) at an average dosage of 30 mg (1.5 ml of 20 mg/ml solution). Analgesia was produced 7.5 +/- 4.3 minutes after injection, extended between spinal cord segments T13 and L3 on both sides of the spinal column, and lasted 47 +/- 18.7 minutes at the T18 dermatome. Procaine hydrochloride was injected into cows (614 +/- 51.5 kg) at a dosage ranging between 75 mg and 100 mg (1.5 ml and 2 ml of 50 mg/ml solution). Analgesia was produced 8.2 +/- 2.0 minutes after injection, extended between spinal cord segments T11 and L4 on both sides of the spinal column, and lasted 47 +/- 17.5 minutes at the T13 dermatome. The critical CSF concentrations of local anesthetics required to eliminate response to pinprick stimulation were 204.4 +/- 90.3 micrograms of mepivacaine/ml in horses and 197.0 +/- 86.1 micrograms of procaine/ml in cows. Average CSF concentrations at 120 minutes after injections were made were 16.8 +/- 15.5 micrograms of mepivacaine/ml and 30.6 +/- 17.1 micrograms of procaine/ml. In in vitro experiments to determine the rates of hydrolysis of mepivacaine and procaine in CSF, significant changes (P greater than 0.05) were not seen in the CSF concentrations of mepivacaine in horses and procaine in cattle after a 120-minute incubation (37 C). The analgesic threshold concentrations of mepivacaine in CSF of horses and procaine in CSF of cows were similar.(ABSTRACT TRUNCATED AT 250 WORDS)     

Repletion of blood selenium concentrations in weaned beef calves

Eighty-three weaned beef calves severely deficient (less than 20 micrograms/L) in blood selenium (Se) were allotted by sex, weight and breed to one of six regimens of Se supplementation for 108 days to examine the efficacy of various Se supplementation programs and to monitor the repletion rate of blood Se concentrations. Cattle in treatment 1 received an IM injection of sodium selenite and an ad libitum feeding of 20 mg Se/kg salt-mineral mixture. Salt-mineral mixtures (treatments 2, 3, 4 and 5) were formulated to contain 20, 40, 80 and 160 mg Se/kg supplement, respectively, and were offered free-choice. Treatment 2 served as the selenium-treated control because 20 mg Se/kg supplement was the maximum permissible by FDA in commercial salt-mineral preparations at the time of this study. Cattle in treatment 6 received a salt-mineral supplement which contained no Se but dried brewers grain (434 micrograms Se/kg) was incorporated in the ration as an organic source of Se and fed at a rate of 1.1 kg/head/day. There was a within group time/treatment interaction (P less than 0.01) among all treatments as blood Se concentrations significantly increased over time. Final mean whole blood Se concentrations for treatments 1-6 were 87.8, 60.6, 95.1, 123.1, 154.2 and 91.4 micrograms/L, respectively. Treatments 1, 3, 4, 5 and 6 effectively increased and maintained whole blood Se concentrations at adequate levels (greater than 70 micrograms/L) by day 84. Treatment 2 (control) increased blood Se during the 108-day study, but blood Se concentrations never exceeded marginal levels (50-70 micrograms/L). Cattle consumed less salt-mineral supplement as the concentration of Na selenite increased from 20 to 160 mg Se/kg supplement.     

Apramycin: minimal inhibitory concentrations for avian Escherichia coli and serum levels after intramuscular injection in turkeys

The minimal inhibitory concentrations (MIC) of apramycin, a unique aminocyclitol antibiotic, for 100 Escherichia coli isolates recovered from clinical cases of avian colibacillosis were determined using the agar dilution method. All isolates were inhibited at apramycin concentration of 8.0 micrograms/ml; 90 and 50% of the isolates were inhibited at 6.6 and 3.4 micrograms/ml, respectively. A commercial injectable product containing 200 mg apramycin/ml was administered intramuscularly (i.m.) to groups of 6- and 12-week-old turkeys at 10, 15 and 20 mg/kg. Apramycin was quickly absorbed from the i.m. injection site. Mean peak serum drug concentrations were reached 1 h after treatment and were 19.5, 27.5 and 36.0 micrograms/ml, respectively. The serum elimination half-life (t 1/2) of the drug ranged between 1.75 h for the 10 mg/kg dose and 2.5 h for the 20 mg/kg dose. Very low concentrations of the drug were found 24 h after treatment. Duration of serum apramycin concentrations in relation to the MIC, dose, and age of birds was determined.     

Comparative pharmacokinetics of antifungal drugs in domestic turkeys, red-tailed hawks, broad-winged hawks, and great-horned owls

The present research was to test in vitro activity of thiabendazole, 5-fluorocytosine, and amphotericin B against 11 isolates of Aspergillus fumigatus from avian species. Additionally, the plasma concentrations of these drugs were determined in four avian species given a range of dosages by oral, intravenous, and intratracheal routes. Thiabendazole inhibited most isolates in vitro at concentrations between 25 and 50 micrograms/ml; however, there were no detectable inhibitory concentrations in the plasma of any species at any of the doses. The arithmetic mean minimum inhibitory in vitro concentration for 5-fluorocytosine against the 11 Aspergillus isolates was 2.73 micrograms/ml. Inhibitory concentrations of 5-fluorocytosine were found 2 and 6 hours post-administration in all species when given oral doses of 30 or 60 mg/kg as a single dose or when given three divided doses a day totaling 120 mg/kg. No inhibitory concentrations were found 24 hours post-administration. Inhibitory concentrations of amphotericin B were found only 2 and 6 hours post-administration in birds receiving three doses of 1.5 mg/kg at 2-hour intervals. The arithmetic mean minimum inhibitory in vitro concentration for amphotericin B against 11 isolates of A. fumigatus was 0.81 micrograms/ml.     

重组猪乳铁蛋白N端多肽对环磷酰胺免疫抑制小鼠免疫功能的影响

研究旨在观察重组猪乳铁蛋白N端多肽(rPLFN)对环磷酰胺所致免疫功能低下小鼠免疫功能的影响。选用体重18～21g的雄性ICR小鼠40只,按试验要求随机分成4组,即12.5mg/kg rPLFN组、25mg/kgrPLFN组、环磷酰胺组和对照组,每组10只;按设计剂量灌胃给药,在第12天时用环磷酰胺50mg/kg腹腔注射建立小鼠免疫低下模型,至第16天检测各组小鼠脾淋巴细胞增殖反应和血清IL-2、TNF-α、IFN-γ含量。结果表明:25mg/kg rPLFN组能拮抗环磷酰胺对小鼠脾淋巴细胞增殖反应的抑制作用(P<0.05);25mg/kg rPLFN组血清中IL-2、IFN-γ、TNF-α含量显著高于模型组(P<0.05)。结果表明,rPLFN对环磷酰胺免疫抑制小鼠的免疫功能有一定的恢复和增强作用。     

Pharmacokinetics of phenobarbital in the horse

Pharmacokinetics of phenobarbital was examined in 6 mature horses after 12 mg of phenobarbital/kg of body weight was infused over 20 minutes. Biexponential decrease in serum phenobarbital concentrations was observed with a distribution-phase half-life of 0.101 +/- 0.086 hour (mean +/- SD) and a terminal-phase elimination half-life of 18.3 +/- 3.65 hours. The volume of distribution at steady state was 0.803 +/- 0.070 L/kg. Total body clearance of phenobarbital was 30.8 +/- 6.2 ml/h/kg. The high clearance in the horse seems to explain the markedly shorter half-life of phenobarbital in this species. Seemingly, 6.65 mg of phenobarbital/kg as a 20-minute infusion given every 12 hours would provide approximate peaks of 29 micrograms/ml and troughs of 15 micrograms/ml. A loading dose of 12 mg of phenobarbital/kg would be appropriate for this regimen.     

鸡防御素Gal-13对雏鸡淋巴细胞增殖功能的影响

为观察鸡防御素Gal-13对雏鸡淋巴细胞增殖功能的影响,以Gal-13为研究对象,在体外培养雏鸡淋巴细胞,运用MTT法首先研究不同质量浓度的Gal-13对抗原刺激的雏鸡外周血淋巴细胞增殖功能的影响,然后选取1mg/L的Gal-13饲喂雏鸡,观察其各免疫器官和外周血淋巴细胞增殖功能的变化.结果发现:体外Gal-13(0.625～1.250 mg/L)提高淋巴细胞的增殖功能,但过高剂量的Gal-13(5～10 mg/L)抑制淋巴细胞的增殖.1 mg/L的Gal-13能够提高雏鸡中枢免疫器官淋巴细胞增殖功能,抑制脾脏淋巴细胞的增殖功能.结果表明,Gal-13能够提高中枢免疫器官的免疫反应,对免疫器官的作用具有一定选择性.